Showing results (1381-1390 of 1,838) with videos related to

Sort By:
Pageof 184
Gastroenterology|August 28, 2014
Development and validation of a symptom-based activity index for adults with eosinophilic esophagitisAlain M Schoepfer, Alex Straumann, Radoslaw Panczak, et al.
Neuro-Oncology|June 11, 2016
Pediatric high-grade glioma: biologically and clinically in need of new thinkingChris Jones, Matthias A Karajannis, David T W Jones, et al.
Science (New York, N.Y.)|October 9, 2020
The mole genome reveals regulatory rearrangements associated with adaptive intersexualityFrancisca M Real, Stefan A Haas, Paolo Franchini, et al.
Nature|April 12, 2021
Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoVAlexey Stukalov, Virginie Girault, Vincent Grass, et al.
The Lancet. Digital Health|May 27, 2026
Artificial intelligence analysis of temporalis muscle thickness for monitoring sarcopenia and clinical outcomes in individuals with paediatric brain tumours: a retrospective cohort studyAnna Zapaishchykova, John Zielke, Divyanshu Tak, et al.
Haematologica|May 28, 2016
Characterization of leukemias with ETV6-ABL1 fusionMarketa Zaliova, Anthony V Moorman, Giovanni Cazzaniga, et al.
Cell|September 30, 2022
Repression and 3D-restructuring resolves regulatory conflicts in evolutionarily rearranged genomesAlessa R Ringel, Quentin Szabo, Andrea M Chiariello, et al.
Applied and Environmental Microbiology|June 9, 2019
Bacillus thuringiensis Cry1Da_7 and Cry1B.868 Protein Interactions with Novel Receptors Allow Control of Resistant Fall Armyworms, Spodoptera frugiperda (J.E. Smith)Yanfei Wang, Jinling Wang, Xiaoran Fu, et al.
Blood|August 27, 2013
Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Munster AML-study groupEva A Coenen, C Michel Zwaan, Dirk Reinhardt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2021
Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT ConsortiumSteven G DuBois, M Meaghan Granger, Susan Groshen, et al.
Pageof 184